Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06397677 · ClinicalTrials.gov registry record
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
A clinical trial of Rheumatoid Arthritis and Interstitial Lung Disease, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 450
- Enrollment target
- 4
- Study locations
NCT06397677: Recruiting study of Rheumatoid Arthritis and Interstitial Lung Disease, sponsored by University of Colorado, Denver.
NCT06397677 is a study of Rheumatoid Arthritis and Interstitial Lung Disease that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 450 participants, below the 4,688-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06397677, a study of Rheumatoid Arthritis and Interstitial Lung Disease, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 4
- Study locations
Study Summary
A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.
Primary Outcome
Through evaluation of baseline CT scans and application of novel quantitative technology, investigators will monitor for specific patterning to identify patients at risk for progression.
Conditions Studied
Interventions
- GENETIC Research Testing Performed (Laboratory)
- DIAGNOSTIC_TEST Information Collected as Standard of Care
- OTHER Research Testing Performed
Study Locations (4)
California
- University of California San Francisco - San Francisco
Colorado
- University of Colorado Denver - Aurora
Kansas
- University of Kansas - Kansas City
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2034-01 |
What NCT06397677 shows while recruiting
NCT06397677 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 4,688-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 3 interventions - of which Research Testing Performed (Laboratory) is the first listed.
NCT06397677 reports a single indexed study location in California, Colorado, Kansas.
Frequently Asked Questions
What is clinical trial NCT06397677 about?
NCT06397677 is a clinical study titled "Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease". A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progressi...
What is the current status of trial NCT06397677?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2024-01-22. Estimated completion is 2034-01.
What conditions does trial NCT06397677 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Interstitial Lung Disease.
What interventions are being tested in trial NCT06397677?
The interventions under investigation include: Research Testing Performed (Laboratory) (GENETIC), Information Collected as Standard of Care (DIAGNOSTIC_TEST), Research Testing Performed (OTHER).
Who is sponsoring clinical trial NCT06397677?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06397677 being conducted?
This trial has 4 study locations across California, Colorado, Kansas, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06397677's enrollment target sits among peer trials
450 44th of 197 higher than 154 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI